David Elvira Martinez | Director
CatSalut, Catalunya Health Service

David Elvira Martinez, Director, CatSalut, Catalunya Health Service

Experienced health economist with strong institutional background and in depth knowledge of market access and public affairs activities in the pharmaceutical sector. With a great deal of experience in consultancy activities at international level related to healthcare systems policies, pharmaceutical business, healthcare reimbursement systems and economic evaluation methods. Main responsibilities carrying out top management duties in several public healthcare organizations and regional ministries in Spain as well as lobbying entities. Advising at regional (Catalonia), national (Spain) and international (World Health Organization) level for healthcare policy planning and financing. 12 years as an Adjunct Faculty Professor in several universities in Spain with over 20 scientific publications and experience as a visiting researcher overseas.


Day 1 Orphan 14th Nov @ 17:25

Discussion: Examining the challenges of valuation from payers and HTAs

  • Pricing and evaluating orphan drugs - present and future
  • What are the interests of payers and HTA bodies when considering how to improve access to rare disease therapies?
  • How will the increase of cancer, biosimilars and gene therapies change the pricing and access?

back to speakers